3 years for Creaspine!
3 years it’s 3 products with FDA approval and distributed in United States and Europe
"Patient driven, users' needs focusing, innovation are our leitmotiv. We are very pleased to bring new technology to Spine Market as a visible PEEK with Barium Sulfate corpectomy VBR.This will help surgeons dealing with corpectomy patients follow up" said Dr Philippe Jenny, President of Creaspine.
For the next years, Creaspine keeps selecting concepts and carrying device opportunities and patents, to deliver fully registered (CE, FDA), ready to commercialize, innovative products.
|
